Nominations are now open for Co-Chair of the Cochrane Governing Board.

The deadline for receiving nominations is the end of the day on Tuesday 14th April 2020 in any timezone.

The Board has two Co-Chairs, to share workload, utilize complementary skills and experience, and permit continuity through the Co-Chairs stepping down at different times. The new Co-Chair will work alongside current Co-Chair Catherine Marshall and replace Professor Martin Burton, whose term is coming to an end.

The Co-Chairs are accountable to the Governing Board, and to the members of the organization. They are expected to have leadership skills, to be fully consultative, to have vision, to be adept at dealing with people, to be able to solve problems and resolve conflicts effectively, to communicate well, and to be able to represent Cochrane in a variety of different settings.  

Members of the Governing Board have responsibilities both as trustees under UK charity law and as directors under UK company law. All Board members must adhere to the Governing Board Charter and agree to the Code of Conduct.

Eligibility

Anyone who holds, or has held, a leadership position within Cochrane is eligible to apply for the position of Co-Chair. Experience of membership of the Governing Board is advantageous but not essential.

Responsibilities

Co-Chairs agree upon an appropriate division of responsibilities, which include:

• Chairing Board meetings and various Board sub-committees;
• Chairing Cochrane’s Annual General Meeting;
• Leading strategic decision-making and effective governance for the organization;
• Advising and guiding the Chief Executive Officer (CEO), the Editor in Chief and the Central Executive Team in working towards delivery of Cochrane’s strategy;
• Serving as official spokesperson(s) for Cochrane and the Board, with the authority to delegate this responsibility to others;
• Responding to issues raised by members of the organization, outside the remits of the CEO and the Editor in Chief;
• Pursuing those initiatives and projects agreed by the Board to be the responsibility of the Co-Chairs;
• Conducting the performance appraisal of the CEO.

Time commitment

There is a need for a minimum of eight hours per week for the Co-Chairs combined, but with an expectation that a combined total of up to thirty hours per week might sometimes be needed (not including the full-time requirements at the times of the two face-to-face Board meetings per year).

This year, the new Co-Chair must be available to travel to Toronto, Canada, for the Board’s meeting 1-3 October 2020, and to stay on to attend the Cochrane Colloquium, 4-7 October.

Term of office

The Co-Chairs hold office for two years. They may continue to hold office for a further two-year term with the approval of the Board. The term of the new Co-Chair will begin on 1 September 2020, with a possible handover period with Martin Burton in July and August 2020.

Remuneration

Cochrane’s Articles of Association allow the organization to remunerate the Co-Chairs, where necessary, for work conducted on behalf of the organization, up to a maximum of one day per week per person, pro rata. This cap is set by the organization and reviewed as necessary. All travel and other expenses are covered.

How to nominate

Candidates standing for appointment must submit their nomination by email to elections@cochrane.org, by the deadline of the end of the day Tuesday 14th April in any timezone.

The Board appoints the Co-Chairs. Candidates should be nominated by three members of Cochrane as defined by the Membership Terms & Conditions, including a current member of the Board. Current Board members may only nominate one candidate each and a serving Co-Chair is not permitted to provide a Letter of Support for a fellow Board member standing for a Co-Chair appointment.
Candidates must include:

• A completed Co-Chair Candidate Statement, which includes a declaration of conflicts of interest (including direct and indirect conflicts, and professional relationships to other members of the Board, and other boards they may sit on).
• Letters of Support from three Cochrane members acting as 'nominators' for the candidate, including one current member of the Board, supplying the following information:

1. Name and role in Cochrane of the person writing the Letter of Support.
2. Statement about the capacity in which they know the nominee, why they consider the nominee to be an appropriate candidate in the light of the Co-Chair job description as set out in this policy and the extent to which they think the nominee has the necessary attributes.

The Co-Chair Candidate Statement of the successful applicant (i.e. the new Co-Chair) will be published on the Cochrane Community website and will remain on the website against the name of the Co-Chair for the duration of their term on the Board.  For this reason, the Co-Chair Candidate Statement document template must be used; and full addresses, email addresses and/or unencrypted e-signatures excluded. Photographs (including personal headshots) are also not permitted.

Where an individual is selected as Co-Chair but is not a member of the Board, they are an appointed member of the Board (under Article 15.2 of the Articles of Association) and count as such in determining the proportion of elected and appointed members. This appointment must be approved at the next Annual General Meeting. The term of a newly appointed Co-Chair will begin at the following face-to-face meeting of the Board.

For more information, please refer to the Board electoral and appointment procedure on the Cochrane Community website or contact Lucie Binder, Head of Governance and Strategy at elections@cochrane.org.

Important dates